Skip to main content

Susman Sally

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Susman Sally as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ULS UL Solutions Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 18, 2024 (view filing)Apr 162 daysSusman SallyDirectorPPurchaseClass A Common Stock+3.57K$28.00+$100.0KNew position3.57K afterFrom original

PFE Pfizer Inc

Executive Vice President1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 30, 2021 (view filing)Nov 264 daysSusman SallyExecutive Vice PresidentSSale−44.3K$54.52−$2.42M−33.1%89.6K after14 lots